Lck Jnk 1 Llc

13F Holdings History for Scinai Immunotherapeutics Ltd. - American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

Investment type: Equity / American Depositary Shares, each representing 4,000 Ordinary Shares, no par value
Latest Disclosed Ownership: 80.8K shares
Security Ownership: 9.5%

LCK JNK 1 LLC ownership in Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value

2025-03-04 - LCK JNK 1 LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 80.8K shares of Scinai Immunotherapeutics Ltd. American Depositary Shares, each representing 4,000 Ordinary Shares, no par value. This represents 9.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
LCK JNK 1 LLC	9.5%			80.8K				13G/A	2/9/2025	4 Mar 2025 21:58:02
LCK JNK 1 LLC	9.5%			80.8K				13G	2/9/2025	24 Feb 2025 06:04:51